Nanovesicles-Mediated Drug Delivery for Oral Bioavailability Enhancement
Yuehong Ren,Linghui Nie,Shiping Zhu,Xingwang Zhang
DOI: https://doi.org/10.2147/IJN.S382192
IF: 7.033
2022-10-17
International Journal of Nanomedicine
Abstract:Yuehong Ren, 1, &ast Linghui Nie, 2, &ast Shiping Zhu, 3 Xingwang Zhang 1 1 Department of Pharmaceutics, College of Pharmacy, Jinan University, Guangzhou, People's Republic of China; 2 ASD Medical Rehabilitation Center, the Second People's Hospital of Guangdong Province, Guangzhou, People's Republic of China; 3 Department of Chinese Traditional Medicine, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shiping Zhu, Department of Chinese Traditional Medicine, The First Affiliated Hospital of Jinan University, 613 West Huangpu Avenue, Guangzhou, 513630, People's Republic of China, Email Xingwang Zhang, Department of Pharmaceutics, College of Pharmacy, Jinan University, No. 855 East Xingye Avenue, Guangzhou, 511443, People's Republic of China, Email Bioavailability is an eternal topic that cannot be circumvented by peroral drug delivery. Adequate blood drug exposure after oral administration is a prerequisite for effective treatment. Nanovesicles as pleiotropic oral vehicles can solubilize, encapsulate, stabilize an active ingredient and promote the payload absorption via various mechanisms. Vesicular systems with nanoscale size, such as liposomes, niosomes and polymersomes, provide a versatile platform for oral delivery of drugs with distinct nature. The amphiphilicity of vesicles in structure allows hydrophilic and lipophilic molecule(s) either or both to be loaded, being encapsulated in the aqueous cavity or the inner core, respectively. Depending on high oral transport efficiency based on their structural flexibility, gastrointestinal stability, biocompatibility, and/or intestinal epithelial affinity, nanovesicles can markedly augment the oral bioavailability of various poorly absorbed drugs. Vesicular drug delivery systems (VDDSs) demonstrate a lot of preferences and are becoming more prominent of late years in biomedical applications. Equally, these systems can potentiate a drug's therapeutic index by ameliorating the oral absorption. This review devotes to comment on various VDDSs with special emphasis on the peroral drug delivery. The classification of nanovesicles, preparative processes, intestinal transport mechanisms, in vivo fate, and design rationale were expounded. Knowledge on vesicles-mediated oral drug delivery for bioavailability enhancement has been properly provided. It can be concluded that VDDSs with many merits will step into an energetic arena in oral drug delivery. Keywords: vesicles, oral drug delivery, bioavailability, liposomes, niosomes, exosomes Oral administration is a preferred option for the treatment of most types of chronic diseases, besides the formulation of insoluble drugs. 1 Many medications are taken orally since they are intended to produce a systemic effect after absorption, arriving to different parts of the body via the bloodstream. However, the unique and diverse physiology of the gastrointestinal (GI) tract, eg, polytropic pH, mucus turnover, sophisticated cell lines, immunologic defense and excretory elimination, constitutes a formidable barrier to oral drug delivery. 2 There is no universal drug delivery system as yet, behaving perfectly to achieve all the lofty goals, though plenty of attempts have been made to idealize the efficiency of oral delivery. In recent years, a number of novel drug delivery systems have emerged in an attempt to cater the urgency of oral administration. Among these, vesicles have drawn much interest owing to the outstanding ability of addressing sundry problems encountered in oral drug delivery. 3–5 Figure 1 Vesicular drug delivery systems available for oral administration. Figure 2 Transport route and mechanisms of vesicles across the absorptive epithelia. Abbreviations : CME, clathrin-mediated endocytosis; CvME, caveolin-mediated endocytosis; AtypE, clathrin-/caveolin-independent atypical endocytosis. Figure 3 Mechanisms of vesicles-mediated oral drug delivery: ( A ) conventional VDDSs utilizing pinocytosis or unspecific endocytosis on the basis of supersaturation, and ( B ) targeted VDDSs via targeting to specialized intestinal epithelial cells for the promotion of absorption. Figure 4 Confocal laser scanning microscopy imaging of curcumin-loaded TPGS-bilosomes and suspensions in the duodenum following oral administration. Reproduced from Hegazy H, Amin MM, Fayad W, et al. TPGS surface modified bilosomes as boosting cytotoxic oral delivery systems of curcumin against doxorubicin resistant MCF-7 breast cancer cells. Int J Pharm. 2022;619:121717. Copyright (2022), with p -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology